These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9301676)

  • 1. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
    Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP
    J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.
    Monn JA; Valli MJ; Johnson BG; Salhoff CR; Wright RA; Howe T; Bond A; Lodge D; Spangle LA; Paschal JW; Campbell JB; Griffey K; Tizzano JP; Schoepp DD
    J Med Chem; 1996 Jul; 39(15):2990-3000. PubMed ID: 8709133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
    Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A
    Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus.
    Panatier A; Poulain DA; Oliet SH
    Neuropharmacology; 2004 Sep; 47(3):333-41. PubMed ID: 15275822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
    Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
    Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems.
    Gelmi ML; Caputo F; Clerici F; Pellegrino S; Giannaccini G; Betti L; Fabbrini L; Schmid L; Palego L; Lucacchini A
    Bioorg Med Chem; 2007 Dec; 15(24):7581-9. PubMed ID: 17900912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
    Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M
    Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R; Golding N; Challiss RA
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclobutane quisqualic acid analogues as selective mGluR5a metabotropic glutamic acid receptor ligands.
    Littman L; Tokar C; Venkatraman S; Roon RJ; Koerner JF; Robinson MB; Johnson RL
    J Med Chem; 1999 May; 42(9):1639-47. PubMed ID: 10229632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.
    Ornstein PL; Bleisch TJ; Arnold MB; Wright RA; Johnson BG; Schoepp DD
    J Med Chem; 1998 Jan; 41(3):346-57. PubMed ID: 9464366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes.
    Nishi N; Odagaki Y; Koyama T
    Br J Pharmacol; 2000 Aug; 130(7):1664-70. PubMed ID: 10928972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical and pharmacological characterization of metabotropic glutamate receptors of the vestibular end organs in the frog.
    Andrianov GN; Puyal J; Raymond J; Ventéo S; Demêmes D; Ryzhova IV
    Hear Res; 2005 Jun; 204(1-2):200-9. PubMed ID: 15925205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.
    Sibille P; Lopez S; Brabet I; Valenti O; Oueslati N; Gaven F; Goudet C; Bertrand HO; Neyton J; Marino MJ; Amalric M; Pin JP; Acher FC
    J Med Chem; 2007 Jul; 50(15):3585-95. PubMed ID: 17602546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.